News About: R&D


10 year drug development plans for treatment of liver cancer and hepatitis initiated.

The project "drug development for liver cancer and hepatitis" was adopted to the "10 year plan" in the technology of next generation that was planned and proceeded as the 21st century intellectual intensified and high...

Domestic drug maker keenly interested in new drug development.

Many research oriented domestic drug makers have made quite an investment for a new drug development since long time, and as a result, several new drugs seem to appear in the market this year such as a diagnostic reag...

Plans to establish "Awards for new drug development".

The New Drug Development Promotion Association (Chairman: Mr. Kim Sun-jin, President: Mr. Lee Kang-choo) took an opening ceremony of "New Drug Development Exhibition" located at Seoul Science Hall on March 12 and anno...

A new drug for neutrocytopenia on successful development in Korea.

Dong-A pharmaceutical company (President : Yoo Choong-shik) announced recently that Leucosteam, a new drug for treatment of neutrocytopenia, G-CSF, had been successfully developed for the first time in Korea and the 3...

Strategic tie-up between LG and SB for new drug development.

A local company has made a strategic tie-up with a foreign multinational pharmaceutical corporation for a new drug development in whole process from the early research to the final commercialization phase. LG chemi...

Patent diputy between local and foreign drug firms likely to multiply.

Ensuing the patent dispute on Sod. alendronic acid between local and foreign invested companies, there may appear other possibilities of patent argument over Cisapride and Itraconazole preparations along with local co...

More international pressure to waive local clinical study for new drugs.

American pharmaceutical research based manufacturers association (PhRMA) requested USTR to designate Korea along with Argentina as the country of first convention (PFC) in connection with the exemption of loca...

R&D investment found 4% level of net sales.

Domestic drug makers revealed their hot enthusiasm in developing new drugs amid expectation of the first birth of domestic new drug this year. Despite a difficult management environment under the IMF economic crisis t...

Patent dispute on Interferon anticancer drug ended.

A 8 year patent dispute on Interferon between Cheil Jedang and Roche, a Swiss multinational pharmaceutical corporation, has been ended recently. The 2nd division of the Supreme Court (Chief Chancellor: Cho Moo-jae)...

New Drug R&D Union to build up technology mart.

So called Pharma-Tech Plaza, a technological cooperation market, seems to be established this year, where respective specialists in the new drug research and development and their projects would be gathered together f...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.